INDIACSR News Network
NOIDA: Jubilant Life Sciences Limited, an integrated Pharmaceuticals and Life Sciences Company announced today that it has received prestigious ‘NDTV Profit Business Leadership Award 2012’ in the category of ‘Corporate Social Responsibility’at an award ceremony held on April 8, 2013 at New Delhi.
On behalf of the Company Mr. Shyam S Bhartia, Chairman & Managing Director, Jubilant Life Sciences Limited received the award from Chief Guest Dr.Montek Singh Ahluwalia, Deputy Chairman, Planning Commission, Government of India.
Speaking on the development, Mr. Shyam S Bhartia, Chairman & Managing Director and Mr. Hari S Bhartia, Co-Chairman & Managing Director, said, “We are delighted to receive this award, Corporate Social Responsibility is an integral part of how we conduct our business. Our efforts are directed towards empowering communities, we believe that for sustainable social intervention, the people themselves would have to be the drivers. We focus on community development through intervention in primary education, basic Healthcare Service, and Livelihood generation programs targeted on improving the employability of women and local youth”.
The social initiatives of the Company are carried out under the aegis of Jubilant Bhartia Foundation (JBF). The foundation follow 4P model (Public-Private-People-Partnership) and it covers 65 villages in India, educating over 13,500 children, providing basic healthcare to 350,000 people and training up to 2500 youth every year.
Jubilant Life Sciences Limited is a global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Generics, Specialty Pharmaceuticals and Life Science Ingredients. It also provides Services in Contract Manufacturing and Drug Discovery and Development. The Company’s strength lies in its unique offerings of Pharmaceutical and Life Sciences products and services across the value chain.
With 10 world-class manufacturing facilities in India, US and Canada and a team of almost 6400 multicultural people across the globe, the Company is committed to deliver value to its customers spread across over 90 countries. The Company is well recognized as a ‘Partner of Choice’ by leading pharmaceuticals and life sciences companies globally.